Table 1 Descriptive characteristics
From: Secondary consent to biospecimen use in a prostate cancer biorepository
N | n | (%) | |
|---|---|---|---|
Outcomes | |||
Does patient agree to allow study team to analyze other factors? | 1931 | ||
Yes | 1918 | (99.33) | |
No | 13 | (0.67) | |
Consent for future use | 1931 | ||
Yes always | 197 | (10.2) | |
Yes conditional | 1703 | (88.19) | |
Never | 31 | (1.61) | |
Predictors | |||
Age at diagnosis | 1859 | ||
Mean (SD) | 61.03 | (7.41) | |
Race | 1931 | ||
White | 1682 | (87.11) | |
Black | 237 | (12.27) | |
Other | 12 | (0.62) | |
Family history of prostate cancer | 1733 | ||
Yes | 615 | (35.49) | |
No | 1118 | (64.51) | |
Marital status | 1322 | ||
Married | 1133 | (85.70) | |
Separated/divorced/widowed | 155 | (11.72) | |
Never married | 34 | (2.57) | |
Employment status | 1312 | ||
Employed | 712 | (54.27) | |
Retired | 530 | (40.40) | |
Unemployed | 47 | (3.58) | |
Other | 23 | (1.75) | |
Smoking status | 1889 | ||
Never smoked | 918 | (48.60) | |
Former smoker | 753 | (39.86) | |
Current smoker | 218 | (11.54) | |
Clinical stage | 1881 | ||
T1c | 1512 | (80.38) | |
T2a/T2b/T2c | 369 | (19.62) | |
Gleason score | 1888 | ||
2–6 | 1147 | (60.75) | |
7 | 587 | (31.09) | |
8+ | 154 | (8.16) | |